Endocrine, Metabolic & Nephrology
Endocrine and Metabolic
Clinlogix is considered an industry leader in drug development for diabetes, obesity, and metabolic disorders. Recently, Clinlogix has conducted several large trials in diabetic nephropathy patients and CKD patients. As a result, Clinlogix has developed the relationships and therapeutic expertise for development projects dealing with renal disorders. Clinlogix understands the complex metabolic conditions that cause CKD and, perhaps more importantly, understands the medical complications experienced by patients with CKD and Early Stage Renal Disease (ESRD). In addition, Clinlogix has a working knowledge of the international landscape of nephrology investigative sites that regularly participate and successfully enroll in nephrology studies.
Clinlogix has the experience to conduct trials in renal-impaired patients, including patients currently undergoing dialysis, and in patients suffering from diabetic neuropathy, as well as other chronic kidney diseases (CKD). Our expertise in nephrology drug development enables us to collaborate closely with sponsors on clinical and regulatory aspects of their drug development programs.